TreeFrog Therapeutics was selected to join the French Tech 120 ! Launched by the French government, this program dedicated to startups in the hyper-growth phase offers unprecedented support to 123 fast-growing companies. By pooling the skills of numerous government agencies, ministries and public services, the French...
TreeFrog Therapeutics starts 2020 with a new video, recapitulating the benefits of C-Stem™ to provide access for millions of patients to safe and affordable cell therapies....
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] TreeFrog Therapeutics－すべての人に細胞治療を（幹細胞治療の会社） [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] C-Stem™：幹細胞のカプセル化のメカニズムについて（TreeFrog Therapeutics） [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] 幹細胞の大量生産のメカニズムについて [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] C-Stem™：細胞治療のコスト削減のメカニズムについて [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row]...
Our CSO, Maxime Feyeux, contributed to a roundtable entitled "What breakthrough innovations to develop next-generation bioproduction factories ?" organized by BPI France and Medicen in Paris on October 10th 2019, during the Innogeneration event....
TreeFrog Therapeutics has developed C-Stem™ : a proprietary technology platform for the mass-production of iPSc-based cell therapies. C-Stem™ secures cell quality (100% genomic integrity), volumes (x100 cell amplification per week) and dramatically reduces cell therapy costs (by 10 today, by 100 tomorrow). Learn about C-Stem...
This new explainer video provides a quick overview of C-Stem™, the patented technology operated by TreeFrog Therapeutics to mass-produce stem cells for cell therapy....
"Four months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office Aquitaine Science Transfert to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the ENSTBB, on the campus of Bordeaux, the start-up aims at providing the...
We were interviewed by the regional TV France 3. Sorry for english speakers, the video is in French...
Just a short video released by the French Ministry of Higher Education, Research and Innovation after we were awarded the special prize "Coup de Coeur" of the i-LAB innovation contest !...
Maxime Feyeux & Kevin Alessandri, co-founders of TreeFrog Therapeutics, attended the award ceremony of the i-LAB contest on July 5th 2018. Result : Great Prized awarded by the Ministry of Higher Education, Research and Innovation herself ! Congratulations to the other laureates....